Login to update email address, newsletter preferences and use bookmarks.

While immune checkpoint inhibition has reshaped the treatment of multiple solid tumors, prostate cancer has remained largely refractory to therapies directed against PD-1, PD-L1, or CTLA-4. In ...

WCE 2019: Ambulatory Percutaneous Nephrolithotomy in Free - Standing Surgery Center: Outcomes of the First 550 Cases WCE 2019: Investigating the Role of Smaller Tract Percutaneous Nephrolithotomy in ...

Transdermal Application of H100 Gel to the Penile Shaft in Patients with Peyronie's Disease Infiltrates the Tunica Albuginea - Beyond the Abstract ...

ESMO 2024, High and Intermediate Risk Non Muscle Invasive Bladder Cancer (HMR-NMIBC), Trifunctional Anti-EpCAM/CD3 bsAb Catumaxomab Intravesically, catumaxomab (CAT), EpCAM+ tumor cells.

Read the Full Video Transcript Sue Yom: Hi, everybody. As they say on the Monty Python show, “And now for something completely different.” I do appreciate the engagement of patient concerns, and I ...

Development of a Risk Predictive Model for Erectile Dysfunction at 12 Months after COVID-19 Recovery: A Prospective Observational Study - Beyond the Abstract ...

Amy Pearlman discusses penile rehabilitation strategies following prostate cancer treatment. Dr. Pearlman shares her expertise on vacuum pump therapy as a crucial component of penile rehabilitation.

ASCO GU 2025, M1 Prostate cancer, Transdermal Oestradiol Patches, Transdermal Oestradiol Patches as Androgen Deprivation Therapy, Combining Transdermal Oestradiol Patches with Androgen Receptor ...

UroToday - GU OncToday brings coverage of the clinically relevant content needed to stay at the forefront of the dynamic field of GU oncology and urology.

(UroToday.com) Prostate-specific membrane antigen (PSMA) is expressed on prostate cancer cells and can be used as a target for both imaging and treatment tools in prostate cancer. PSMA can be ...

UroToday - GU OncToday brings coverage of the clinically relevant content needed to stay at the forefront of the dynamic field of GU oncology and urology.